Effects of Teucrium polium ethyl acetate extract on serum, liver and muscle triglyceride content of sucrose-induced insulin resistance in rat

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 1, 2012, Pages 347-355

  Mousavi, Seyyedeh Elaheh ^a   Shahriari, Ali ^a   Ahangarpour, Akram ^b   Vatanpour, Hossein ^a   Jolodar, Abbas ^c  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Insulin resistance; Rat; Sucrose; Teucrium polium; Triglyceride

Indexed keywords

GLUCOSE; GLYCOGEN; INSULIN; LEPTIN; TEUCRIUM POLIUM ETHYL ACETATE EXTRACT; TEUCRIUM POLIUM EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; FASTING INSULIN RESISTANCE INDEX; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84858605022     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Choi K and Kim YB. Molecular mechanism of insulin resistance in obesity and type 2 diabetes Korean. J. Intern. Med. (2010) 25: 119-129.
2. Wolf RN and Grundy SM. Influence of weight reduction on plasma lipoproteins in obese patients. Arteribsclerosis (1983) 3: 160-169.
3. Seppa la-Lindroos A, Vehkavaara S, Ha kinen AM, Goto T, Westerbacka J, Sovijarvi A, Halavaara J and Yki-Jarvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. (2002) 87: 3023-3028.
4. Tiikkainen M, Tamminen M, Hakkinen AM, Bergholm R, Vehkavaara S, Halavaara J, Teramo K, Rissanen A and Yki-Ja rvinen H. Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes. Res. (2002) 10: 859-867.
5. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins ABJ and Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes (1997) 46: 983-988.
6. Falholt K, Jensen I, Lindkaer Jensen S, Mortensen H, Volund A, Heding LG, Noerskov Peterson P and Falholt W. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet Med. (1988) 5: 27-31
7. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J and McGarry JD. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intra-myocellular lipid accumulation and insulin resistance in rats. Diabetes (2001) 50: 123-130.
8. Oakes ND, Camilleri S, Furler SM, Chisholm DJ and Kraegen EW. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism (1997) 46: 935-942.
9. Smith Jr LH, Ettinger RH and Seligson D. A comparison of the metabolism of fructose and glucose in hepatic disease and diabetes mellitus. J. Clin. Invest. (1953) 32: 273-282.
10. Sato Y, Ito T, Udaka N, Kanisawa M, Noguchi Y, Cushman SW and Satoh S. Immunohistochemical localization of facilitated-diffusion glucose transporters in rat pancreatic islets. Tissue Cell (1996) 28: 637-643.
11. Basciano H, Federico L and Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metab. (2005) 2: 5.
12. Qu S, Su D, Altomonte J, Kamagate A, He J, Perdomo G, Tse T, Jiang Y, Dong HH. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am. J. Physiol. Endocrinol. Metab. (2007) 292: 421-434.
13. Mukherjee P, Maiti K, Mukherjee K and Houghton PJ. Leads from Indian medicinal plants with hypoglycemic potentials. J. Ethnopharmacol. (2006) 106: 1-28.
14. Khoshnood-Mansoorkhani MJ, Moein MR and Oveisi N. Anticonvulsant activity of Teucrium polium against seizure induced by PTZ and MES in mice. Iranian J. Pharm. Res. (2010) 9: 395-401.
15. Autore G, Capasso F, De-Fusco R, Fasulo MP, Lembo M, Mascolo N and Menghini A. Antipyretic and antibacterial actions of Teucrium polium L. Pharmacol. Res. (1984) 16: 21-29.
16. Sharifian Z, Vodgani M, Hajati pour J and Kamalinejad M. Immunological effects of Teucrium polium on neutrophils. Iranian J. Pharm. Res. (2004) 3: 61-61.
17. Karimi F, Abbasi S and Bateni AR. The effect of Teucrium polium on blood glucose in diabetes mellitus Type 2. Iranian South Med. J. (2002) 4: 96-103.
18. Gharaibeh MN, Elayan HH and Salhab AS. Hypoglycemic effects of Teucrium polium. J. Ethnopharmacol. (1988) 24: 93-99.
19. Safaei A and Haghi G. Identification and quantitative determination of flavonoids in the aerial parts of Teucrium polium by HPLC. Iranian J. Pharm. Res.(2004) 3: 90-90.
20. Yazdanparast R, Esmaeili MA and Ashrafi Helan J. Teucrium polium extract effects pancreatic function of streptozotocin diabetic rates: a histopathological examination. Iran Biomed. J. (2005) 9: 81-85.
21. Rasekh HR, Khoshnood-Mansourkhani MJ and Kamalinejad M. Hypolipidemic effect of Teucrium polium in rats. Fitoterapia (2001) 72: 937-939.
22. Rasekh HR, Yazdanpanah H, Hosseinzadeh L, Bazmohammadi N and Kamalinejad M. Acute and subchronic toxicity of Teucrium polium total extract in rats. Pharmacol. Res. (2005) 4: 245-249.
23. Ardestani A and Yazdanparast R. Inhibitory effects of ethyl acetate extract of Teucrium polium on in-vitro protein glycoxidation. Food Chem. Toxicol. (2007) 45: 2402-2411.
24. Kadifkova PT, Kulevanova S, Gjorgoski I, Bogdanova M and Petrushevska G. Hepatoprotective effect of the ethyl acetate extract of Teucrium polium L. against carbontetrachloride-induced hepatic injury in rats. Acta Pharma. (2007) 57: 241-248.
25. Kadifkova PT, Kulevanova S and Stefova M. In-vitro antioxidant activity of some Teucrium species (Lamiaceae). Acta Pharm. (2005) 55: 207-214.
26. Esmaeili MA and Yazdanparast R. Hypoglycaemic effect of Teucrium polium: studies with rat pancreatic islets. J. Ethnopharmacol. (2004) 95: 27-30.
27. Neri P and Fring CS. Improved method for determination of triglycerides in serum. Clin. Chem. (1973) 19: 1201-1203.
28. Duncan MH, Singh BM, Wise PH, Carter G and Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet (1995) 346: 120-121
29. Lo S, Russell JC and Taylor AW. Determination of glycogen in small tissue sample. J. Appl. Physiol. (1970) 28: 234-236.
30. Hara A and Radian NS. Lipid extraction of tissues with a low toxicity solvent. Anal. Biochem. (1978) 90: 420-426.
31. Ahren B and Scheurink AJ. Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur. J. Endocrinol. (1998) 139: 461-7.
32. Ryu MH and Cha YS. The effects of high-fat or high-sucrose diet on serum lipid profiles, hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and the acetyl-CoA carboxylase mRNA levels in rats. J. Biochem. Mol. Biol. (2003) 36: 312-8.
33. Arner P. Insulin resistance in type 2 diabetes: role of fatty acid. Metab. Res. Rev. (2002) 18: S5-9.
34. Tomas E, Lin YS, Dagher Z, Saha A, Luo Z, Ido Y and Ruderman NB. Hyperglycemia and insulin resistance: possible mechanisms. Ann. NY Acad. Sci. (2002) 967: 43-51.
35. Nestel PJ and Hirsch EZ. Triglyceride turnover after diets rich in carbohydrate or animal fat. Australas Ann. Med. (1965) 14: 265-269.
36. Nestel PJ, Carroll KF and Havenstein N. Plasma triglyceride response to carbohydrates, fats and caloric intake. Metabolism (1970) 19: 1-18.
37. Fredrickson DS, Ono K and Davis LL. Lipolytic activity of post-heparin plasma in hyperglyceridemia. J. Lipid Res. (1963) 4: 24-33.
38. Jackson RL, Yates MT, McNerney CA and Kashyap ML. Diet and HDL metabolism: high carbohydrate vs: high fat diets. Adv. Exp. Med. Biol. (1987) 210: 165-172.
39. Mancini M, Mattock M, Rabaya E, Chait A and Lewis B. Studies of the mechanisms of carbohydrateinduced lipaemia in normal man. Atherosclerosis (1973) 17: 445-454.
40. MacDonald I. The effect of various dietary carbohydrates on the serum lipids during a five day regimen. Clin. Sci. (1965) 29: 193-197.
41. Nestel PJ, Carroll KF and Havenstein N. Plasma triglyceride response to carbohydrates, fats and caloric intake. Metabolism (1970) 19: 1-18.
42. Hjermann I, Enger CS, Helgeland A, Holme I, Leren P and Trygg K. The effect of dietary changes on high density lipoprotein cholesterol. Am. J. Med. (1979) 66: 105-109.
43. Mensink RP and Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet (1987) 1: 122-125.
44. Shahraki MR, Arab MR, Mirimokaddam E and Mony Jey P. The effect of Teucrium polium (calpoureh) on liver function, serum lipids and glucose in diabetic male rats. Biomed. (2007) 11: 65-68.
45. Kamel A. 7-Epi-eudesmanes from Teucrium polium. J. Nat. Prod. (1995) 58: 428-431.
46. Risk AM, Hammouda FM, Rimpler H and Kamel A. Iridois and flavonoids of Teucrium polium herb. Planta Med. (1989) 2: 87-88.
47. Hii CS and Howell SL. Effect of flavonoids on insulin secretion and 45 Ca+2 handling in rat islets of Langerhans. J. Endocrin. (1985) 107: 1-8.
48. Reinner E, Bjorkhem I, Angelin B, Ewerth S and Einarsson K. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7-alpha-hydroxylase activity. J. Gastroenterol. (1989) 97:1498-1505.
49. Bouche C, Serdy S, Kahn CR and Goldfine AB. The cellular fate of glucose and its relevance in Type 2 diabetes. Endocr. Res. (2004) 25: 807-830.
50. de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G and Alberti KGMM. Hyperleptinaemia: the missing link in the, metabolic syndrome? Diabet. Med. (1997) 14: 200-8.
51. Beltowski J. Leptin and atherosclerosis. Atherosclerosis (2006) 189: 47-60.
52. Beltowski J. Role of leptin in blood pressure regulation and arterial hypertension. J. Hypertens. (2006) 24: 789-801.